Recent Investment Analysts’ Ratings Updates for Cardinal Health (CAH)

A number of research firms have changed their ratings and price targets for Cardinal Health (NYSE: CAH):

• 2/6/2026 – Cardinal Health was given a new $255.00 price target on by analysts at Morgan Stanley.
• 2/6/2026 – Cardinal Health was given a new $252.00 price target on by analysts at Robert W. Baird.
• 2/6/2026 – Cardinal Health was given a new $260.00 price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
• 2/6/2026 – Cardinal Health had its price target raised by analysts at Mizuho from $222.00 to $235.00. They now have an “outperform” rating on the stock.
• 2/6/2026 – Cardinal Health had its price target raised by analysts at Evercore ISI from $250.00 to $260.00.
• 2/5/2026 – Cardinal Health had its “outperform” rating reaffirmed by analysts at Evercore ISI.
• 2/5/2026 – Cardinal Health had its “outperform” rating reaffirmed by analysts at Evercore Inc. They now have a $260.00 price target on the stock.
• 2/5/2026 – Cardinal Health had its price target raised by analysts at Leerink Partners from $240.00 to $268.00. They now have an “outperform” rating on the stock.
• 1/29/2026 – Cardinal Health had its price target raised by analysts at Morgan Stanley from $224.00 to $245.00. They now have an “overweight” rating on the stock.
• 1/27/2026 – Cardinal Health had its “buy” rating reaffirmed by analysts at TD Cowen.
• 1/23/2026 – Cardinal Health had its price target raised by analysts at Argus from $211.00 to $232.00. They now have a “buy” rating on the stock.
• 1/22/2026 – Cardinal Health was upgraded by analysts at Argus to a “strong-buy” rating.
• 1/22/2026 – Cardinal Health had its price target raised by analysts at Jefferies Financial Group Inc. from $220.00 to $270.00. They now have a “buy” rating on the stock.
• 1/21/2026 – Cardinal Health had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 1/15/2026 – Cardinal Health had its price target raised by analysts at Wells Fargo & Company from $221.00 to $237.00. They now have an “overweight” rating on the stock.
• 1/14/2026 – Cardinal Health was given a new $250.00 price target on by analysts at Robert W. Baird.
• 1/13/2026 – Cardinal Health was given a new $240.00 price target on by analysts at Leerink Partners.
• 1/12/2026 – Cardinal Health was given a new $222.00 price target on by analysts at Mizuho.
• 1/9/2026 – Cardinal Health was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $244.00 price target on the stock, up previously from $190.00.

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.